• 1
    Fernández A., Gil E., Cartelle M., Pérez A., Beceiro A., Mallo S., Tomás M.M., Pérez-Llarena F.J., Villanueva R., Bou G. (2007) Interspecies spread of CTX-M-32 extended-spectrum β-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression. J Antimicrob Chemother 59: 8417.
  • 2
    Thomson K.S. (2010) Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues. J Clin Microbiol 48: 101925.
  • 3
    Hawkey P.M., Jones A.M. (2009) The changing epidemiology of resistance. J Antimicrob Chemother 64: i3i10.
  • 4
    Van Duin D., Kaye K.S., Neuner E.A., Bonomo R.A. (2013) Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis 75: 11520.
  • 5
    Perez F., Van Duin D. (2013) Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients. Cleve Clin J Med 80: 22533.
  • 6
    Nordmann P., Naas T., Poirel L. (2011) Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17: 17918.
  • 7
    Khan A.U., Nordmann P. (2012) Spread of carbapenemase NDM-1 producers: the situation in India and what may be proposed. Scand J Infect Dis 44: 5315.
  • 8
    Mena A., Plasencia V., García L., Hidalgo O., Ayestarán J.I., Alberti S., Borrell N., Pérez J.L., Oliver A. (2006) Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 44: 28317.
  • 9
    Poirel L., Castanheira M., Carrër A., Rodriguez C.P., Jones R.N., Smayevsky J., Nordmann P. (2011) OXA-163, an OXA-48-related class D β-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob Agents Chemother 55: 254651.
  • 10
    Ellem J., Partridge S.R., Iredell J.R. (2011) Efficient direct extended-spectrum β-lactamase detection by multiplex real-time PCR: accurate assignment of phenotype by use of a limited set of genetic markers. J Clin Microbiol 49: 30747.
  • 11
    Tonkic M., Mohar B., Sisko-Kraljevic K., Mesko-Meglic K., Goic-Barisic I., Novak A., Kovacic A., Punda-Polic V. (2010) High prevalence and molecular characterization of extended-spectrum β-lactamase-producing Proteus mirabilis strains in southern Croatia. J Med Microbiol 59: 118590.
  • 12
    Boyd D.A., Tyler S., Christianson S., McGeer A., Muller M.P., Willey B.M., Bryce E., Gardam M., Nordmann P., Mulvey M.R. (2004) Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum β-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 48: 375864.
  • 13
    Ellington M.J., Kistler J., Livermore D.M., Woodford N. (2007) Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases. J Antimicrob Chemother 59: 3212.
  • 14
    Ohana S., Leflon V., Ronco E., Rottman M., Guillemot D., Lortat-Jacob S., Denys P., Loubert G., Nicolas-Chanoine M.H., Gaillard J.L., Lawrence C. (2005) Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC β-lactamase in a teaching hospital admitting disabled patients. Antimicrob Agents Chemother 49: 20957.
  • 15
    Nordmann P., Boulanger A.E., Poirel L. (2012) NDM-4 metallo-β-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob Agents Chemother 56: 21846.
  • 16
    Pillai D.R., Melano R., Rawte P., Lo S., Tijet N., Fuksa M., Roda N., Farrell D.J., Krajden S. (2009) Klebsiella pneumoniae Carbapenemase, Canada. Emerg Infect Dis 15: 8279.
  • 17
    Khanfar H.S., Bindayna K.M., Senok A.C., Botta G.A. (2009) Extended spectrum β-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings. J Infect Dev Ctries 3: 2959.
  • 18
    Al-Zarouni M., Senok A., Rashid F., Al-Jesmi S.M., Panigrahi D. (2008) Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med Princ Pract 17: 326.
  • 19
    Kader A.A., Kumar A., Kamath K.A. (2007) Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 28: 11146.
  • 20
    Cantón R., Akóva M., Carmeli Y., Giske C.G., Glupczynski Y., Gniadkowski M., Livermore D.M., Miriagou V., Naas T., Rossolini G.M., Samuelsen Ø., Seifert H., Woodford N., Nordmann P. (2012) Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18: 41331.
  • 21
    Bindayna K.M., Senok A.C., Jamsheer A.E. (2009) Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in Bahrain. J Infect Public Health 2: 12935.
  • 22
    Oberoi L., Singh N., Sharma P., Aggarwal A. (2013) ESBL, MBL and Ampc β lactamases producing superbugs—havoc in the intensive care units of Punjab India. J Clin Diagn Res 7: 703.
  • 23
    Bakthavatchalu S., Shakthivel U., Mishra T. (2013) Detection of ESBL among ampc producing Enterobacteriaceae using inhibitor-based method. Pan Afr Med J 14: 28.
  • 24
    Liu H.Y., Lin H.C., Lin Y.C., Yu S.H., Wu W.H., Lee Y.J. (2011) Antimicrobial susceptibilities of urinary extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. J Microbiol Immunol Infect 44: 3648.
  • 25
    Kashanian J., Hakimian P., Blute M., Jr, Wong J., Khanna H., Wise G., Shabsigh R. (2008) Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU Int 102: 16347.